Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

JNJ – Johnson & Johnson

Float Short %

0.71

Margin Of Safety %

-5

Put/Call OI Ratio

0.78

EPS Next Q Diff

-0.2

EPS Last/This Y

5.01

EPS This/Next Y

0.5

Price

179.26

Target Price

177.2

Analyst Recom

2.2

Performance Q

17.48

Relative Volume

1.13

Beta

0.38

Ticker: JNJ




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-25JNJ168.350.741.02428721
2025-07-28JNJ166.210.770.59414390
2025-07-29JNJ168.140.730.65435974
2025-07-30JNJ167.890.771.24445505
2025-07-31JNJ164.770.791.06452456
2025-08-01JNJ167.340.780.72465597
2025-08-04JNJ171.080.790.70453187
2025-08-05JNJ170.810.830.52460193
2025-08-06JNJ170.620.820.67467647
2025-08-07JNJ171.550.820.85475487
2025-08-08JNJ173.360.820.54481306
2025-08-11JNJ174.050.810.56468315
2025-08-12JNJ172.780.800.42478941
2025-08-13JNJ174.370.800.64486472
2025-08-14JNJ174.720.800.37492469
2025-08-15JNJ176.650.780.46500565
2025-08-18JNJ176.210.780.30440754
2025-08-19JNJ177.730.770.71454460
2025-08-20JNJ178.840.770.64469234
2025-08-21JNJ179.020.780.97481215
2025-08-22JNJ179.250.780.31485222
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-25JNJ168.3013.83217.810.86
2025-07-28JNJ165.9613.62261.010.85
2025-07-29JNJ168.1113.62983.610.85
2025-07-30JNJ167.2613.62514.010.85
2025-07-31JNJ164.7413.62228.010.85
2025-08-01JNJ167.3313.63107.510.85
2025-08-04JNJ171.0413.63292.410.85
2025-08-05JNJ170.7413.62608.510.85
2025-08-06JNJ170.5913.62633.510.85
2025-08-07JNJ171.5313.62816.410.85
2025-08-08JNJ173.3313.62959.110.85
2025-08-11JNJ173.9213.62756.210.85
2025-08-12JNJ172.7613.62483.810.85
2025-08-13JNJ174.4213.62930.510.85
2025-08-14JNJ174.7313.62709.610.85
2025-08-15JNJ176.6613.62977.110.85
2025-08-18JNJ176.2513.62595.310.85
2025-08-19JNJ177.8013.62910.910.85
2025-08-20JNJ178.8213.62823.310.85
2025-08-21JNJ179.0113.62685.910.85
2025-08-22JNJ179.2613.62711.710.85
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-25JNJ-1.251.240.76
2025-07-28JNJ-1.250.860.76
2025-07-29JNJ-1.250.860.76
2025-07-30JNJ-1.250.860.76
2025-07-31JNJ-1.250.860.76
2025-08-01JNJ-1.250.860.76
2025-08-04JNJ-1.250.890.76
2025-08-05JNJ-1.250.890.76
2025-08-06JNJ-1.250.890.76
2025-08-07JNJ-1.250.890.76
2025-08-08JNJ-1.250.890.76
2025-08-11JNJ-1.250.950.76
2025-08-12JNJ-0.840.950.71
2025-08-13JNJ-0.840.950.71
2025-08-14JNJ-0.840.950.71
2025-08-15JNJ-0.840.950.71
2025-08-18JNJ-0.84-0.200.71
2025-08-19JNJ-1.35-0.200.71
2025-08-20JNJ-1.35-0.200.71
2025-08-21JNJ-1.35-0.200.71
2025-08-22JNJ-1.35-0.200.71
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

2.77

Avg. EPS Est. Current Quarter

2.75

Avg. EPS Est. Next Quarter

2.57

Insider Transactions

-1.35

Institutional Transactions

-0.2

Beta

0.38

Average Sales Estimate Current Quarter

23725

Average Sales Estimate Next Quarter

24047

Fair Value

170.57

Quality Score

97

Growth Score

69

Sentiment Score

92

Actual DrawDown %

4

Max Drawdown 5-Year %

-18.4

Target Price

177.2

P/E

19.18

Forward P/E

15.83

PEG

2.91

P/S

4.76

P/B

5.5

P/Free Cash Flow

23.28

EPS

9.35

Average EPS Est. Cur. Y​

10.85

EPS Next Y. (Est.)

11.35

Target Price Estimates Raised

2

Target Price Estimates Lowered

Profit Margin

25.01

Relative Volume

1.13

Return on Equity vs Sector %

4.2

Return on Equity vs Industry %

-4.2

EPS 1 7Days Diff

EPS 1 30Days Diff

0.24

EBIT Estimation

2711.7
Johnson & Johnson
Sector: Healthcare
Industry: Drug Manufacturers - General
Employees: 138100
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; circulatory restoration products for the treatment of calcified coronary artery and peripheral artery diseases; and neurovascular care that treats hemorrhagic and ischemic stroke. This segment offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. The company was founded in 1886 and is based in New Brunswick, New Jersey.
stock quote shares JNJ – Johnson & Johnson Stock Price stock today
news today JNJ – Johnson & Johnson stock forecast ,stock prediction 2023 2024 2025
marketwatch JNJ – Johnson & Johnson yahoo finance google finance
stock history JNJ – Johnson & Johnson invest stock market
stock prices JNJ premarket after hours
ticker JNJ fair value insiders trading